Search

Displaying results 3731 - 3740 of 9322 in total
  1. Drug

    o-Cymen-5-ol

    go.drugbank.com/drugs/DB15901
    Investigational

    Mixtures: Be Clean
  2. Drug

    VP025

    go.drugbank.com/drugs/DB05133
    Experimental

    It also shows the ability to reduce inflammation across the blood-brain barrier and improve correlates of memory and learning function. … It is considered to be a systemic anti-inflammatory and neuroprotective agent.

  3. Drug

    Uric acid

    go.drugbank.com/drugs/DB08844
    Investigational

    Uric acid is the last product of purine metabolism in humans. The formation of uric acid is through the enzyme xanthine oxidase, which oxidizes oxypurines. … Normally a small amount of uric acid is present in the body, but when there is an excess amount in the blood, called hyperuricemia, this can lead to gout and formation of kidney stones.

  4. Drug

    Bambusa arundinacea stem

    go.drugbank.com/drugs/DB14588
    Investigational

    Mixtures: Re-action E
  5. Drug

    Maltodextrin

    go.drugbank.com/drugs/DB12583
    Investigational

    Mixtures: Re-action E
  6. Drug

    Metixene

    go.drugbank.com/drugs/DB00340
    Approved

    Metixene (or methixene) is a anticholinergic used as an antiparkinsonian agent.

  7. Drug

    Aminocaproic acid

    go.drugbank.com/drugs/DB00513
    ApprovedInvestigational

    An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.

    International brands: E-CaproMixtures: Relief and Nature Toothpast E Jasmine Mint
  8. Drug

    Myrrh

    go.drugbank.com/drugs/DB11605
    ApprovedInvestigational

    Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, obtained from Commiphora abyssinica, Burseraceae.

    Products: Teinture De Myrrhe
  9. Drug

    DDP-225

    go.drugbank.com/drugs/DB05642
    Investigational

    Noradrenaline and serotonin are neurotransmitters that are known to be involved in the control of the gastrointestinal system. … The unique combination of noradrenaline reuptake inhibition and 5-HT3 antagonism in one orally delivered compound represents a novel approach to treating IBS-d and other functional GI diseases.

  10. Drug

    Elacridar

    go.drugbank.com/drugs/DB04881
    Investigational

    Development is assumed to have been discontinued. … In many cases, the appearance of multidrug resistance in cancer is due to a change in expression of protein inhibitors. As of August 2007 elacridar was not listed on GSK's product pipeline.